GH1 and Prader-Willi syndrome: In analyses conducted on the full cohort but restricted to individuals with PWS alive and living in Sweden from 2005, somatotropin was prescribed in 63%, anti-diabetic medications in 18%, and thyroid hormones in 16% of the individuals with PWS (Table 1).